DMPI - DelMar Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 59.83M
Enterprise Value 36.7M
Trailing P/E N/A
Forward P/E 1-1.49
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)8.27
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2017
Most Recent Quarter (mrq)Mar 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-120.27%
Return on Equity (ttm)-255.62%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-11.62M
Diluted EPS (ttm)-0.6240
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.51M
Total Cash Per Share (mrq)0.39
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.79
Book Value Per Share (mrq)0.05

Cash Flow Statement

Operating Cash Flow (ttm)-10.77M
Levered Free Cash Flow (ttm)-6.55M

Trading Information

Stock Price History

Beta 2.09
52-Week Change 3-66.66%
S&P500 52-Week Change 315.23%
52 Week High 32.2900
52 Week Low 30.3260
50-Day Moving Average 30.6153
200-Day Moving Average 30.9206

Share Statistics

Avg Vol (3 month) 3186.3k
Avg Vol (10 day) 3135.06k
Shares Outstanding 522.01M
Float 18.93M
% Held by Insiders 17.65%
% Held by Institutions 115.70%
Shares Short (Jun 15, 2018) 41.56M
Short Ratio (Jun 15, 2018) 48.39
Short % of Float (Jun 15, 2018) 47.46%
Short % of Shares Outstanding (Jun 15, 2018) 47.07%
Shares Short (prior month May 15, 2018) 41.71M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A